The size of the MEA Pharmaceutical Gelatin Market is projected to grow at a sluggish CAGR between 2022 to 2027.
The versatility and unique functional qualities of gelatin in pharmaceutical applications and the rising demand for gelatin capsules due to the rise in chronic illnesses and the aging population are driving the market growth. Hard capsules, softgel capsules, and tablets have a gelatin coating that hides the odor of the medicine while also making swallowing more straightforward. Furthermore, gelatin's qualities give protection against environmental changes such as oxygen or moisture, extending the shelf life of these products. However, rising demand for bovine bone gelatin as a substitute for pig meat gelatin in the pharmaceutical market will propel the MEA pharmaceutical gelatin market forward. The growing demand for gelatin's unique functional characteristics, including gelling, adhesion, coating, binding, and film-building, which make it ideal for usage in the pharmaceutical market, is likely to boost market expansion. Growth is also projected to be aided by technological advancements in cost-effective manufacturing products.
Pharmaceutical gelatin growth in the MEA region is likely to be restrained throughout the forecast period due to rising demand for plant-based pharmaceutical products and associated modifications in product portfolios by capsule producers. In addition, to prevent the spread of animal-borne diseases, strict laws control the handling of raw materials and products in this nation. This can wreak havoc on supplies in the event of export or import bans and outbreaks of various diseases in specific places at any particular time. These factors will represent a substantial challenge to the market's expansion during the forecast period. In addition, however, cultural constraints on the consumption of porcine and bovine gelatin and growing raw material prices may hinder the pharmaceutical gelatin market.
This research report on the MEA pharmaceutical gelatin market has been segmented and sub-segmented into the following categories:
By Function:
By Source:
By Application:
By Country:
Technological advancements and increased disease incidence are driving pharmaceutical gelatin. For example, gelatin made from the pig is used as a stabilizer in vaccines to ensure their safety and effectiveness throughout storage and transportation, which is a driving force for the current market's strong demand for pharmaceutical-grade gelatin. The MEA market is expected to develop quickly during the projected period. Capsule adoption in the MEA is likely to be driven by the presence of several manufacturers in the UAE and Nigeria, expansion in the pharmaceutical business, less stringent laws in the nutraceutical industry, a growing focus on generics, and greater healthcare awareness. Saudi Arabia is the largest pharmaceutical market in the Gulf Cooperation Council (GCC) in terms of GDP and population, and it positively impacts the Saudi Arabian pharmaceutical packaging market. In addition, emerging markets, such as the Middle East and Africa, provide significant market expansion opportunities. Global raw gelatin and gelatin capsule manufacturers have expanded their firm presence and manufacturing capacity in these areas in response to this demand. During the projection period, rising demand in emerging economies, combined with decreased raw material and labor prices, would provide an opportunity for market expansion.
KEY MARKET PLAYERS:
Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG are a few of the promising companies operating in the pharmaceutical gelatin market in the MEA region.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region